Radiofrequency Ablation Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth, Trends, Competitive Scenario And Forecasts, 2012 To 2020

Table of Contents

Chapter 1. Executive Summary

Chapter 2. Radiofrequency Ablation Devices Industry Outlook
2.1. Market Segmentation
2.2. Market Size and Growth Prospects
2.3. Radiofrequency Ablation Devices - Market dynamics
2.3.1. Market Driver Analysis
2.3.2. Market Restraint Analysis
2.4. Key Opportunities Prioritized
2.5. Radiofrequency Ablation Devices - PESTEL Analysis
2.6. Radiofrequency Ablation Devices Company Market Share Analysis, 2013

Chapter 3. Radiofrequency Ablation Devices Application Outlook
3.1. Surgical Oncology Volume and Revenue Estimates, 2012 - 2020
3.2. Cardiology & Cardiac Rhythm Management Volume and Revenue Estimates, 2012 - 2020
3.3. Pain Management Volume and Revenue Estimates, 2012 - 2020
3.4. Gynecology Volume and Revenue Estimates, 2012 - 2020
3.5. Hypertension Volume and Revenue Estimates, 2012 - 2020
3.6. Cosmetology Volume and Revenue Estimates, 2012 - 2020

Chapter 4. Radiofrequency Ablation Devices Product Outlook
4.1. Radiofrequency ablation devices market share, by product, 2013 & 2020
4.2. Capital Equipment
4.2.1. Market Estimates, By Application, 2012 - 2020, Revenue & Volume
4.3. Reusable Equipment
4.3.1. Market Estimates, By Application, 2012 - 2020, Revenue & Volume
4.3.1.1. Reusable Radiofrequency Probes
4.3.1.2. Reusable Radiofrequency Electrodes
4.4. Disposable Equipment
4.4.1. Market Estimates, By Application, 2012 - 2020, Revenue & Volume
4.4.1.1. Disposable Radiofrequency Cannulas
4.4.1.2. Disposable Radiofrequency Needles
4.4.1.3. Disposable Radiofrequency Single-Use probes
4.4.1.4. Disposable Radiofrequency Single-Use Electrodes

Chapter 5. Radiofrequency Ablation Devices Regional Outlook
5.1. Radiofrequency ablation devices revenue share by region, 2012 & 2020
5.2. North America
5.2.1. Market Estimates and Forecasts, by Application
5.2.2. Market Estimates and Forecasts, by Product
5.3. Europe
5.3.1. Market Estimates and Forecasts, by Application
5.3.2. Market Estimates and Forecasts, by Product
5.4. Asia Pacific
5.4.1. Market Estimates and Forecasts, by Application
5.4.2. Market Estimates and Forecasts, by Product
5.5. RoW
5.5.1. Market Estimates and Forecasts, by Application
5.5.2. Market Estimates and Forecasts, by Product

Chapter 6 Competitive Landscape
6.1 Accuray
6.1.1 Company Overview
6.1.2 Financial Performance
6.1.3 Product Benchmarking
6.1.4 Strategic Initiatives
6.2 Biosense Webster
6.2.1 Company Overview
6.2.2 Financial Performance
6.2.3 Product Benchmarking
6.2.4 Strategic Initiatives
6.3 Cosman Medical Inc.
6.3.1 Company Overview
6.3.2 Financial Performance
6.3.3 Product Benchmarking
6.3.4 Strategic Initiatives
6.4 Diros Technology Inc.
6.4.1 Company Overview
6.4.2 Financial Performance
6.4.3 Product Benchmarking
6.5 NeuroTherm (St. Jude Medical).
6.5.1 Company Overview
6.5.2 Financial Performance
6.5.3 Product Benchmarking
6.5.4 Strategic Initiatives
6.6 St. Jude Medical.
6.6.1 Company Overview
6.6.2 Financial Performance
6.6.3 Product Benchmarking
6.6.4 Strategic Initiatives
6.7 Stryker Corporation.
6.7.1 Company Overview
6.7.2 Financial Performance
6.7.3 Product Benchmarking
6.7.4 Strategic Initiatives
6.8 Kimberly-Clark.
6.8.1 Company Overview
6.8.2 Financial Performance
6.8.3 Product Benchmarking
6.8.4 Strategic Initiatives
6.9 RF Medical Co. Ltd.
6.9.1 Company Overview
6.9.2 Financial Performance
6.9.3 Product Benchmarking
6.9.4 Strategic Initiatives
6.10 AngioDynamics.
6.10.1 Company Overview
6.10.2 Financial Performance
6.10.3 Product Benchmarking
6.10.4 Strategic Initiatives
6.11 Covidien.
6.11.1 Company Overview
6.11.2 Financial Performance
6.11.3 Product Benchmarking
6.11.4 Strategic Initiatives
6.12 DFINE Inc.
6.12.1 Company Overview
6.12.2 Financial Performance
6.12.3 Product Benchmarking
6.12.4 Strategic Initiatives
6.13 STARmed.
6.13.1 Company Overview
6.13.2 Financial Performance
6.13.3 Product Benchmarking
6.13.4 Strategic Initiatives
6.14 Boston Scientific.
6.14.1 Company Overview
6.14.2 Financial Performance
6.14.3 Product Benchmarking
6.14.4 Strategic Initiatives

Chapter 7. Methodology and Scope
7.1. Research Methodology
7.2. Research Scope & Assumption
7.3. List of Data Sources